Skip to main content

Table 1 Clinical and biological characteristics of the NPC patients

From: Quantitative expression analysis and prognostic significance of the BCL2-associated Xgene in nasopharyngeal carcinoma: a retrospective cohort study

Number of patients 88
Gender (Male/Female) 51/37
  Median (range)
Age (years) 46.5 (10.0 – 80.0)
Disease-free survival (months) 30 (2 – 90)
Overall survival (months) 36 (2 – 90)
  Number of patients (%)
T – primary tumor extent  
T0 0 (0%)
T1 8 (9.1%)
T2 25 (28.4%)
T3 19 (21.6%)
T4 36 (40.9%)
N – regional lymph nodes  
N0 14 (15.9%)
N1 14 (15.9%)
N2 28 (31.8%)
N3 32 (36.4%)
M – distant metastasis  
M0 61 (69.3%)
M1 27 (30.7%)
TNM stage  
I 2 (2.3%)
II 12 (13.6%)
III 22 (25.0%)
IV A 12 (13.6%)
IV B 13 (14.8%)
IV C 27 (30.7%)